Claims
- 1. A compound comprising the formula
- 2. A compound according to claim 1 wherein the compound comprises the formula
- 3. A compound of claim 1, wherein Q is a substituted or unsubstituted phenyl ring.
- 4. A compound of claim 1, wherein Q is a substituted or unsubstituted heteroaryl.
- 5. A compound of claim 1, wherein Q is a substituted or unsubstituted heteroaryl selected from the group consisting of furan, thiophene, pyrrole, pyrazole, triazole, isoxazole, oxazole, thiazole, isothiazole, oxadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, benzofuran, isobenzofuran, benzothiophene, isobenzothiophene, indole, isobenzazole, quinoline, isoquinoline, cinnoline, quinazoline, naphthyridine, pyridopyridine, quinoxaline, phthalazine, benthiazole, and triazine.
- 6. A compound according to claim 1, wherein at least one X in the six membered ring is a substituted carbon atom.
- 7. A compound according to claim 1, wherein at least one of the X substituents in the six membered ring is —CF.
- 8. A compound according to claim 1, wherein M comprises a member selected from the group consisting of trifluoroacetyl (—C(O)—CF3), —NH—P(O)OH—CH3, sulfonamides (—SO2NH2), hydroxysulfonamides (—SO2NHOH), thiols(—SH), and carbonyl groups having the formula —C(O)—R13 wherein R13 is hydroxylamino, hydroxyl, amino, alkylamino, or an alkoxy group.
- 9. A compound according to claim 1, wherein M is selected from the group consisting of:
- 10. A compound according to claim 1, wherein M comprises a hydroxamic acid moiety.
- 11. A compound according to claim 1, wherein -Q-L-M is
- 12. A compound comprising the formula
- 13. A compound according to claim 12, wherein the compound comprises the formula
- 14. A compound according to claim 12, wherein at least one of R2, R3, R4, or R5 is fluorine.
- 15. A compound according to claim 12, wherein M comprises a member selected from the group consisting of trifluoroacetyl (—C(O)—CF3), —NH—P(O)OH—CH3, sulfonamides (—SO2NH2), hydroxysulfonamides (—SO2NHOH), thiols(—SH), and carbonyl groups having the formula —C(O)—R13 wherein R13 is hydroxylamino, hydroxyl, amino, alkylamino, or an alkoxy group.
- 16. A compound according to claim 12, wherein M is selected from the group consisting of:
- 17. A compound according to claim 12, wherein M comprises a hydroxamic acid moiety.
- 18. A compound according to claim 12, wherein -Q-L-M is
- 19. A compound comprising a formula selected from the group consisting of:
- 20. A compound according to claim 19, wherein the compound comprises the formula
- 21. A compound according to claim 19, wherein at least one of R6, R7, R8, and R9 is fluorine.
- 22. A compound according to claim 19, wherein M comprises a member selected from the group consisting of trifluoroacetyl (—C(O)—CF3), —NH—P(O)OH—CH3, sulfonamides (—SO2NH2), hydroxysulfonamides (—SO2NHOH), thiols(—SH), and carbonyl groups having the formula —C(O)—R13 wherein R13 is hydroxylamino, hydroxyl, amino, alkylamino, or an alkoxy group.
- 23. A compound according to claim 19, wherein M is selected from the group consisting of:
- 24. A compound according to claim 19, wherein M comprises a hydroxamic acid moiety.
- 25. A compound according to claim 19, wherein -L-M is
- 26. A compound comprising a formula selected from the group consisting of:
- 27. A compound according to claim 26, wherein the compound comprises the formula
- 28. A compound according to claim 26, wherein M comprises a member selected from the group consisting of trifluoroacetyl (—C(O)—CF3), —NH—P(O)OH—CH3, sulfonamides (—SO2NH2), hydroxysulfonamides (—SO2NHOH), thiols(—SH), and carbonyl groups having the formula —C(O)—R13 wherein R13 is hydroxylamino, hydroxyl, amino, alkylamino, or an alkoxy group.
- 29. A compound according to claim 26, wherein M is selected from the group consisting of:
- 30. A compound according to claim 26, wherein M comprises a hydroxamic acid moiety.
- 31. A compound according to claim 26, wherein -L-M is
- 32. A compound according to claim 26, wherein at least one of R6, R7, R8, and R9 is fluorine.
- 33. A compound according to claim 26, wherein at least one X in the six membered ring is a substituted carbon atom.
- 34. A compound according to claim 26, wherein at least one of the X substituents in the six membered ring is —CF.
- 35. A compound comprising a formula selected from the group consisting of:
- 36. A compound according to claim 35, wherein the compound comprises the formula
- 37. A compound according to claim 35, wherein at least one of R2, R3, R4, or R5 is fluorine.
- 38. A compound according to claim 35, wherein at least one of R6, R7, R8, and R9 is fluorine.
- 39. A compound according to claim 35, wherein M comprises a member selected from the group consisting of trifluoroacetyl (—C(O)—CF3), —NH—P(O)OH—CH3, sulfonamides (—SO2NH2), hydroxysulfonamides (—SO2NHOH), thiols(—SH), and carbonyl groups having the formula —C(O)—R13 wherein R13 is hydroxylamino, hydroxyl, amino, alkylamino, or an alkoxy group.
- 40. A compound according to claim 35, wherein M is selected from the group consisting of:
- 41. A compound according to claim 35, wherein M comprises a hydroxamic acid moiety.
- 42. A compound according to claim 35, wherein -L-M is
- 43. A compound comprising the formula
- 44. A compound according to claim 43, wherein the substituted or unsubstituted aromatic ring formed when R10 and R11 are taken together is selected from the group consisting of substituted or unsubstituted aryl and heteroaryl.
- 45. A compound according to claim 43, wherein M comprises a member selected from the group consisting of trifluoroacetyl (—C(O)—CF3), —NH—P(O)OH—CH3, sulfonamides (—SO2NH2), hydroxysulfonamides (—SO2NHOH), thiols(—SH), and carbonyl groups having the formula —C(O)—R13 wherein R13 is hydroxylamino, hydroxyl, amino, alkylamino, or an alkoxy group.
- 46. A compound according to claim 43, wherein M is selected from the group consisting of:
- 47. A compound according to claim 43, wherein M comprises a hydroxamic acid moiety.
- 48. A compound according to claim 43, wherein -L-M is
- 49. A compound comprising the formula
- 50. A compound according to claim 49, wherein at least one of R2, R3, R4, or R5 is fluorine.
- 51. A compound according to claim 49, wherein M comprises a member selected from the group consisting of trifluoroacetyl (—C(O)—CF3), —NH—P(O)OH—CH3, sulfonamides (—SO2NH2), hydroxysulfonamides (—SO2NHOH), thiols(—SH), and carbonyl groups having the formula —C(O)—R3 wherein R13 is hydroxylamino, hydroxyl, amino, alkylamino, or an alkoxy group.
- 52. A compound according to claim 49, wherein M is selected from the group consisting of:
- 53. A compound according to claim 49, wherein M comprises a hydroxamic acid moiety.
- 54. A compound according to claim 49, wherein -L-M is
- 55. A compound comprising the formula:
- 56. A compound according to claim 55, wherein at least one of R2, R3, R4, or R5 is fluorine.
- 57. A compound according to claim 55, wherein M comprises a member selected from the group consisting of trifluoroacetyl (—C(O)—CF3), —NH—P(O)OH—CH3, sulfonamides (—SO2NH2), hydroxysulfonamides (—SO2NHOH), thiols(—SH), and carbonyl groups having the formula —C(O)—R13 wherein R13 is hydroxylamino, hydroxyl, amino, alkylamino, or an alkoxy group.
- 58. A compound according to claim 55, wherein M is selected from the group consisting of:
- 59. A compound according to claim 55, wherein M comprises a hydroxamic acid moiety.
- 60. A compound according to claim 55, wherein -L-M is
- 61. A compound comprising the formula:
- 62. A compound according to claim 61 wherein at least one of R2, R3, R4, or R5 is fluorine.
- 63. A compound according to claim 61, wherein M comprises a member selected from the group consisting of trifluoroacetyl (—C(O)—CF3), —NH—P(O)OH—CH3, sulfonamides (—SO2NH2), hydroxysulfonamides (—SO2NHOH), thiols(—SH), and carbonyl groups having the formula —C(O)—R13 wherein R13 is hydroxylamino, hydroxyl, amino, alkylamino, or an alkoxy group.
- 64. A compound according to claim 61, wherein M is selected from the group consisting of:
- 65. A compound according to claim 61, wherein M comprises a hydroxamic acid moiety.
- 66. A compound according to claim 61, wherein -L-M is
- 67. A compound selected from the group consisting of:
3-[3-(1H-Benzoimidazol-2-yl)-phenyl]-N-hydroxy-acrylamide; N-Hydroxy-3-[3-(1-methyl-1H-benzoimidazol-2-yl)-phenyl]-acrylamide; N-Hydroxy-3-[3-(1-isopropyl-1H-benzoimidazol-2-yl)-phenyl]-acrylamide; (±)-3-{3-[1-(1-Ethyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; N-Hydroxy-3-{3-[1-(1-methyl-piperidin-4-yl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; N-Hydroxy-3-[3-(1-piperidin-4-ylmethyl-1H-benzoimidazol-2-yl)-phenyl]-acrylamide; N-Hydroxy-3-{3-[1-(2-morpholin-4-yl-ethyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; N-Hydroxy-3-[3-(1-phenyl-1H-benzoimidazol-2-yl)-phenyl]-acrylamide; 3-{3-[1-(4-Chloro-phenyl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; N-Hydroxy-3-{3-[1-(4-methoxy-phenyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; N-Hydroxy-3-{3-[1-(4-phenoxy-phenyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; 3-{3-[1-(4-Benzyloxy-phenyl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; 3-[3-(1-Benzyl-1H-benzoimidazol-2-yl)-phenyl]-N-hydroxy-acrylamide; 3-{3-[1-(2-Chloro-benzyl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; 3-{3-[1-(3-Chloro-benzyl)-1H-benzoimidazol-2-yl]-phenyl)-N-hydroxy-acrylamide; 3-{3-[1-(4-Chloro-benzyl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; N-Hydroxy-3-{3-[1-(2-trifluoromethoxy-benzyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; N-Hydroxy-3-{3-[1-(3-trifluoromethoxy-benzyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; N-Hydroxy-3-{3-[1-(4-pyrazol-1-yl-benzyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; (R)-N-Hydroxy-3-{3-[1-(1-phenyl-ethyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; (S)-N-Hydroxy-3-{3-[1-(1-phenyl-ethyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; (R)-N-Hydroxy-3-13-[1-(1-p-tolyl-ethyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; (R)-3-(3-{1-[1-(4-Fluoro-phenyl)-ethyl]-1H-benzoimidazol-2-yl}-phenyl)-N-hydroxy-acrylamide; N-Hydroxy-3-[3-(1-phenethyl-1H-benzoimidazol-2-yl)-phenyl]-acrylamide; 3-(3-{1-[2-(3-Fluoro-phenyl)-ethyl]-1H-benzoimidazol-2-yl}-phenyl)-N-hydroxy-acrylamide; 3-(3-{1-[2-(4-Fluoro-phenyl)-ethyl]-1H-benzoimidazol-2-yl}-phenyl)-N-hydroxy-acrylamide; N-Hydroxy-3-(3-{1′-[2-(2-methoxy-phenyl)-ethyl]-1H-benzoimidazol-2-yl}-phenyl)-acrylamide; N-Hydroxy-3-(3-{1′-[2-(3-methoxy-phenyl)-ethyl]-1H-benzoimidazol-2-yl}-phenyl)-acrylamide; N-Hydroxy-3-(3-{1-[2-(4-methoxy-phenyl)-ethyl]-1H-benzoimidazol-2-yl}-phenyl)-acrylamide; 3-(3-{1-[2-(2-Chloro-phenyl)-ethyl]-1H-benzoimidazol-2-yl}-phenyl)-N-hydroxy-acrylamide; 3-(3-{1-[2-(3-Chloro-phenyl)-ethyl]-1H-benzoimidazol-2-yl}-phenyl)-N-hydroxy-acrylamide; 3-(3-{1-[2-(4-Chloro-phenyl)-ethyl]-1H-benzoimidazol-2-yl}-phenyl)-N-hydroxy-acrylamide; (±)-3-(3-{1-[2-(4-Fluoro-phenyl)-1-methyl-ethyl]-1H-benzoimidazol-2-yl}-phenyl)-N-hydroxy-acrylamide; (R)-N-Hydroxy-3-{3-[1-(2-phenyl-propyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; (S)-N-Hydroxy-3-{3-[1-(2-phenyl-propyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; (S)-N-Hydroxy-3-{3-[1-(1-hydroxymethyl-2-phenylethyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; (R)-N-Hydroxy-3-{3-[1-(1-hydroxymethyl-2-phenylethyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; (R)-N-Hydroxy-3-{3-[1-(2-hydroxy-2-phenyl-ethyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; N-Hydroxy-3-{3-[1-(2-pyridin-2-yl-ethyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; N-Hydroxy-3-{3-[1-(2-pyridin-3-yl-ethyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; N-Hydroxy-3-{3-[1-(2-pyridin-4-yl-ethyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; N-Hydroxy-3-(3-{1-[2-(1H-indol-3-yl)-ethyl]-1H-benzoimidazol-2-yl}-phenyl)-acrylamide; N-Hydroxy-3-[3-(1-indan-2-yl-1H-benzoimidazol-2-yl)-phenyl]-acrylamide; N-Hydroxy-3-{3-[1-(3-phenyl-propyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; 3-[3-(5-Fluoro-1H-benzoimidazol-2-yl)-phenyl]-N-hydroxy-acrylamide; N-Hydroxy-3-[3-(6-propylsulfanyl-1H-benzoimidazol-2-yl)-phenyl]-acrylamide; N-Hydroxy-3-[3-(7-methyl-1H-benzoimidazol-2-yl)-phenyl]-acrylamide; 2-[3-(2-Hydroxycarbamoyl-vinyl)-phenyl]-3H-benzoimidazole-5-carboxylic acid methyl ester; 3-[3-(6,7-Difluoro-1H-benzoimidazol-2-yl)-phenyl]-N-hydroxy-acrylamide; 3-{3-[1-(4-Methoxy-phenyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylic acid; 3-{3-[1-(4-Benzyloxy-phenyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylic acid; 3-{3-[1-(4-Chloro-phenyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylic acid; (R)-3-(3-{1′-[1-(4-Fluoro-phenyl)-ethyl]-1H-benzoimidazol-2-yl}-phenyl)-acrylic acid; (R)-3-{3-[1-(1-p-Tolyl-ethyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylic acid; 3-{3-[1-(4-Phenoxy-phenyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylic acid; N-(2-Amino-phenyl)-3-{3-[1-(4-methoxy-phenyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; N-(2-Amino-phenyl)-3-{3-[1-(4-benzyloxy-phenyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; N-(2-Amino-phenyl)-3-{3-[1-(4-chloro-phenyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; (R)-N-(2-Amino-phenyl)-3-(3-{1-[1-(4-fluoro-phenyl)-ethyl]-1H-benzoimidazol-2-yl}-phenyl)-acrylamide; (R)-N-(2-Amino-phenyl)-3-{3-[1-(1-p-tolyl-ethyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; N-(2-Amino-phenyl)-3-{3-[1-(4-phenoxy-phenyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; N-Hydroxy-3-[4-(1-phenethyl-1H-benzoimidazol-2-yl)-phenyl]-acrylamide; N-(2-Amino-phenyl)-3-[4-(1-phenethyl-1H-benzoimidazol-2-yl)-phenyl]-acrylamide; 3-[4-(1-Phenethyl-1H-benzoimidazol-2-yl)-phenyl]-acrylic acid; N-Hydroxy-3-{3-[1-(2-piperidin-1-yl-ethyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; N-Hydroxy-3-{3-[1-(trans-4-hydroxy-cyclohexyl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; 3-[3-(1-tert-Butyl-1H-benzoimidazol-2-yl)-phenyl]-N-hydroxy-acrylamide; (±)-3-[3-(1-Cyclohexyl-1H-benzoimidazol-2-yl)-phenyl]-N-hydroxy-acrylamide; 3-{2-[3-(2-Hydroxycarbamoyl-vinyl)-phenyl]-benzoimidazol-1-yl}-piperidine-1-carboxylic acid tert-butyl ester; (±)-N-Hydroxy-3-[3-(1-piperidin-3-yl-1H-benzoimidazol-2-yl)-phenyl]-acrylamide; 3-{3-[1-(2-Diethylamino-ethyl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (±)-N-Hydroxy-3-{3-[1-(1-methyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; (±)-N-Hydroxy-3-{3-[1-(1-isopropyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; (±)-N-Hydroxy-3-(3-{1-[1-(2-hydroxy-ethyl)-piperidin-3-yl]-1H-benzoimidazol-2-yl}-phenyl)-acrylamide; (±)-3-{3-[1-(1-Ethyl-pyrrolidin-2-ylmethyl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (±)-3-{3-[1-(1-Ethyl-pyrrolidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (±)-3-{3-[1-(2-Dimethylamino-ethyl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (±)-3-{3-[1-(2-Dimethylamino-1-methyl-ethyl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (±)-3-{3-[1-(2-Diisopropylamino-ethyl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (±)-3-{3-[1-(1-Aza-bicyclo[2.2.2]oct-2-yl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (R)-3-{3-[1-(1-Ethyl-piperidin-3-yl)-6,7-difluoro-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (R)-3-{3-[1-(1-Ethyl-piperidin-3-yl)-5,6-difluoro-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide-trifluoroacetic acid; (R)-3-{3-[1-(1-Ethyl-piperidin-3-yl)-4,6-difluoro-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (R)-3-{3-[1-(1-Ethyl-piperidin-3-yl)-5,6,7-trifluoro-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (R)-3-{3-[1-(1-Ethyl-piperidin-3-yl)-4,6,7-trifluoro-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (R)-3-{3-[1-(1-Ethyl-piperidin-3-yl)4,5,6,7-tetrafluoro-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (R)-3-{3-[1-(1-Ethyl-piperidin-3-yl)-4-fluoro-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (R)-3-{3-[1-(1-Ethyl-piperidin-3-yl)-5-fluoro-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (R)-3-{3-[1-(1-Ethyl-piperidin-3-yl)-6-fluoro-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (R)-N-Hydroxy-3-{3-[1-(1-isopropyl-piperidin-3-yl)-1H-benzoimidazole-2-yl]-phenyl}-acrylamide; (R)-3-{3-[4-Fluoro-1-(1-isopropyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (R)-3-{3-[5-Fluoro-1-(1-isopropyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (R)-3-{3-[4-Fluoro-1-(1-methyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (R)-3-{3-[5-Fluoro-1-(1-methyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (R)-3-{5-[1-(1-Ethyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-2-fluoro-phenyl}-N-hydroxy-acrylamide; (R)-3-{3-[1-(1-Ethyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-4-fluoro-phenyl}-N-hydroxy-acrylamide; (R)-3-{4-Fluoro-3-[5-fluoro-1-(1-methyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (R)-3-(3-{1-[1-(2,2-Difluoro-ethyl)-piperidin-3-yl]-4-fluoro-1H-benzoimidazol-2-yl}-phenyl)-N-hydroxy-acrylamide; (±)-3-{3-[1-(2-Dimethylamino-2-phenyl-ethyl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (±)-3-{3-[1-(1-Benzyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (±)-N-Hydroxy-3-{3-[1-(1-propyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; (±)-N-Hydroxy-3-{3-[1-(1-isobutyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; (±)-3-{3-[1-(1-Allyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (±)-3-{3-[11-(1-Acetyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (S)-N-Hydroxy-3-{3-[1-(1-methyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; (S)-3-{3-[1-(1-Ethyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (R)-N-Hydroxy-3-{3-[1-(1-methyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-acrylamide; (R)-3-{3-[1-(1-Ethyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-acrylamide; (R)-N-Hydroxy-3-{3-[3-(1-isopropyl-piperidin-3-yl)-3H-imidazo[4,5-b]pyridin-2-yl]-phenyl}-acrylamide; (S)-N-Hydroxy-3-[3-(1-piperidin-3-yl-1H-benzoimidazol-2-yl)-phenyl]-acrylamide; (R)-N-Hydroxy-3-[3-(1-piperidin-3-yl-1H-benzoimidazol-2-yl)-phenyl]-acrylamide; (±)-N-Hydroxy-3-{3-[1-(1-propyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-propionamide; (±)-3-{3-[1-(1-Ethyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-phenyl}-N-hydroxy-propionamide; N-Hydroxy-3-[3-(1-phenethyl-1H-benzoimidazol-2-yl)-phenyl]-propionamide; N-Hydroxy-3-{3-[3-(1-methyl-piperidin-3-yl)-3H-imidazo[4,5-b]pyridin-2-yl]-phenyl}-acrylamide; (R)-3-{3-[3-(1-Ethyl-piperidin-3-yl)-3H-imidazo[4,5-b]pyridin-2-yl]-phenyl}-N-hydroxy-acrylamide; N-Hydroxy-3-[5-(1-phenethyl-1H-benzoimidazol-2-yl)-pyridin-3-yl]-acrylamide; (R)-N-Hydroxy-3-{5-[1-(1-methyl-piperidin-3-yl)-1H-benzoimidazol-2-yl]-pyridin-3-yl}-acrylamide; and (R)-N-Hydroxy-3-{5-[3-(1-methyl-piperidin-3-yl)-3H-imidazo[4,5-b]pyridin-2-yl]-pyridin-3-yl}-acrylamide.
RELATED APPLICATION
[0001] This application claims the benefit of U.S. Provisional Application No. 60/455,437, filed Mar. 17, 2003 and U.S. Provisional Application No. 60/531,203, filed Dec. 19, 2003, each of which are incorporated herein by reference.
Provisional Applications (2)
|
Number |
Date |
Country |
|
60455437 |
Mar 2003 |
US |
|
60531203 |
Dec 2003 |
US |